When prescribing testosterone for gender-affirming therapy in transmasculine adults the provider needs to educate the patient regarding the following adverse effects:

Question

Quizplus · Accepted Answer

Testosterone therapy in transmasculine individuals can lead to erythrocytosis, which is an increase in red blood cells. This condition can increase the risk of thrombosis (blood clots), making it an important adverse effect for patients to be aware of. Testosterone does not significantly increase LDL levels or breast size, and there is no direct evidence linking it to an increased risk of ovarian cancer.

When Prescribing Testosterone for Gender-Affirming Therapy in Transmasculine Adults the Provider